Event Type: Earnings conference call for Analysts and Investors discussing quarterly results.
Event Date and Time: The conference call was held on November 06, 2026. The specific time and time zone were not disclosed in the announcement.
Purpose of Event: Discussion of quarterly earnings results (Q2 FY27 inferred from date).
Timing Relative to Earnings: The meeting occurred after the earnings announcement, as evidenced by the disclosure of the recording availability post-event.
Management Participants: Specific management participants and their designations were not disclosed in this announcement.
Presentation Availability: The audio recording of the conference call is available on the company's investor relations website at: https://investor.symbiotec.com/financials?tab=transcripts
UPSI Statement: The company has implicitly indicated compliance with UPSI regulations by making the recording publicly available on their website, though no explicit UPSI statement is included in this disclosure.
Additional Notes Section
Attachments: No attachments were mentioned as included with this disclosure.
Financial Data Disclosure: No financial data, figures, or performance metrics were disclosed in this announcement. The communication solely addresses the availability of the earnings call recording.
Regulatory Context: This disclosure was made pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
